PhaseBio Pharmaceuticals Inc. (PHAS) climbed 5.18% or 0.26 to $5.28. The market cap of PHAS is $125.68 million. The year to date change is 5.58%. The 52 week price range is from $4.8 to $5.69. Price of PHAS have changed 0.40% during last week. It have changed 0.40% over last month, 0.40% over last 3 months, 0.40% over last 6 months and 0.40% over one year.
The 52-week High is 5.69. It is 7.77% from the current price. The 52-week Low is 4.8. It is -9.09% from current price.
There are some statistics of PHAS. It is has market cap $125.68 million. The share outstanding is 23.80 million. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is -51.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -35.57%.